Sayer Kevin R's Form 4 filing
Dexcom Inc (DXCM) · filed Jul 7, 2026
- Accession no.
- 0001093557-26-000133
- Filed
- Jul 7, 2026, 4:09 PM ET
- Trade date
- Jul 6, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $1.93M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sayer Kevin RCIK 0001286858 | Director, Officer (Executive Chair) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Common Stock | SSaleDisposed | −26,756 | $72.00 | −$1,926,432 | 355,726 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.